Stephen Friend, the president of Sage Bionetworks and the former head of cancer research at Merck, has suggested pooling patient reported data about drugs in a similar manner.
Through Sage Bionetworks, the organization he started in 2010, Friend is championing the principles, practices, and incentives that will define what he believes is a new era of drug discovery.